An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan C. Fox, MD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Miyaodai, Fukuoka, Japan
- Research Site
Sapporo, Hokkaido, Japan
- Research Site
Toride-shi, Ibaraki, Japan
- Research Site
Kawasaki-shi, Kanagawa, Japan
- Research Site
Kyoto, Kyoto, Japan
- Research Site
Ōita, Oita Prefecture, Japan
- Research Site
Naha, Okinawa, Japan
- Research Site
Osaka, Osaka, Japan
- Research Site
Kusatsu-shi, Shiga, Japan
- Research Site
Komatsushima-shi, Tokushima, Japan
- Research Site
Shinagawa-ku, Tokyo, Japan
- Research Site
Davao City, Philippines
- Research Site
Quezon City, Philippines
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2010
- Primary completion
- 31 Mar 2011
- Completion
- 31 Mar 2011
- Last update posted
- 8 Jul 2014
- Registered enrollment
- 146
- Registry id
- NCT01118325
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.